Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16994 | 559 | 41.2 | 44% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1647 | 6393 | WALL SHEAR STRESS//SHEAR STRESS//CAROTID BIFURCATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AGE RELATED DECREASE IN PGI2 PRODUCTION | Author keyword | 1 | 100% | 0% | 2 |
2 | EN FACE TECHNIQUE | Author keyword | 1 | 100% | 0% | 2 |
3 | 15 ISOPROSTANE F 2T | Author keyword | 1 | 50% | 0% | 1 |
4 | ABT INNERE MED 2 KARDIOL | Address | 1 | 50% | 0% | 1 |
5 | ANIMAL MODEL RAT | Author keyword | 1 | 50% | 0% | 1 |
6 | ATHEROSCLEROSIS IN YOUTH | Author keyword | 1 | 50% | 0% | 1 |
7 | AVRUM GUDELSKY | Address | 1 | 50% | 0% | 1 |
8 | BLOOD MONOCYTES | Author keyword | 1 | 50% | 0% | 1 |
9 | ELECTRIC SPIN RESONANCE | Author keyword | 1 | 50% | 0% | 1 |
10 | EXTRACELLULAR LIPID | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | WHITE CARNEAU PIGEONS | 20 | 57% | 4% | 24 |
2 | SHOW RACER PIGEONS | 10 | 58% | 2% | 11 |
3 | EARLY ATHEROGENESIS | 9 | 40% | 3% | 18 |
4 | ACETYLATED LDL BINDING | 7 | 64% | 1% | 7 |
5 | LADEN AORTIC CELLS | 2 | 33% | 1% | 6 |
6 | WHITE CARNEAU | 2 | 44% | 1% | 4 |
7 | ARTERIAL WALL CELLS | 2 | 67% | 0% | 2 |
8 | BETA VLDL UPTAKE | 1 | 100% | 0% | 2 |
9 | LESION PRONE AREAS | 1 | 50% | 0% | 2 |
10 | LYSOSOMAL LIPID ACCUMULATION | 1 | 100% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
THE PATHOGENESIS OF ATHEROSCLEROSIS - ATHEROGENESIS AND INFLAMMATION | 1988 | 645 | 103 | 24% |
A DEFINITION OF INITIAL, FATTY STREAK, AND INTERMEDIATE LESIONS OF ATHEROSCLEROSIS - A REPORT FROM THE COMMITTEE ON VASCULAR-LESIONS OF THE COUNCIL ON ARTERIOSCLEROSIS, AMERICAN-HEART-ASSOCIATION | 1994 | 582 | 121 | 21% |
A DEFINITION OF INITIAL, FATTY STREAK, AND INTERMEDIATE LESIONS OF ATHEROSCLEROSIS - A REPORT FROM THE COMMITTEE ON VASCULAR-LESIONS OF THE COUNCIL ON ARTERIOSCLEROSIS, AMERICAN-HEART-ASSOCIATION | 1994 | 370 | 120 | 22% |
COMPOSITION AND CLASSIFICATION OF HUMAN ATHEROSCLEROTIC LESIONS | 1992 | 129 | 52 | 17% |
Advanced atherosclerotic foam cell formation has features of an acquired lysosomal storage disorder | 2006 | 22 | 77 | 16% |
ATHEROSCLEROSIS - A DEFENSE-MECHANISM GONE | 1993 | 255 | 117 | 12% |
The role of microscopy in understanding atherosclerotic lysosomal lipid metabolism | 2003 | 18 | 92 | 22% |
ATHEROSCLEROSIS AND MACROPHAGES | 1989 | 17 | 75 | 36% |
ULTRASTRUCTURE APPEARANCE OF ATHEROSCLEROSIS IN HUMAN AND EXPERIMENTALLY-INDUCED ANIMAL-MODELS | 1992 | 24 | 102 | 23% |
MECHANISMS OF MONOCYTE RECRUITMENT AND ACCUMULATION | 1993 | 77 | 108 | 17% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ABT INNERE MED 2 KARDIOL | 1 | 50% | 0.2% | 1 |
2 | AVRUM GUDELSKY | 1 | 50% | 0.2% | 1 |
3 | CARDIOVASC CARIM MAASTRICHT | 0 | 33% | 0.2% | 1 |
4 | MED INTERNE ONCOHEMATOL | 0 | 33% | 0.2% | 1 |
5 | SPECIALIZED ATHEROSCLEROSIS | 0 | 33% | 0.2% | 1 |
6 | UNIDAD HISTOQUIM | 0 | 33% | 0.2% | 1 |
7 | ADV MODELS TRANSLAT SCI THER EUT | 0 | 20% | 0.2% | 1 |
8 | HPB LIVER TRANSPLANTAT SURG | 0 | 17% | 0.2% | 1 |
9 | INSERM U1011 | 0 | 17% | 0.2% | 1 |
10 | SAHLGRENS HOSP INTERNAL MED | 0 | 14% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000195863 | ELASTIC TISSUE TEARS//BIOENGINEERING FATIGUE//MURAL ATROPHY |
2 | 0.0000191895 | ARTERIOLOSCLEROSIS//NEPHROSCLEROSIS//DECOMPENSATED BENIGN NEPHROSCLEROSIS |
3 | 0.0000190684 | VESSEL SIMULATING FLOW THROUGH CELL//LOCAL PHARMACOKINETICS//PATHOPHARMACOL UNIT |
4 | 0.0000184599 | C PL RATIO//C PL//FATEBENEFRATELLI FDN |
5 | 0.0000167450 | SMOOTHELIN//SMTNL1//SMEMB |
6 | 0.0000164538 | SCAVENGER RECEPTOR//FRACTIONATED H 3HEPARIN//CLASS A SCAVENGER RECEPTOR |
7 | 0.0000161791 | DIABET CELL BIOL//CELL BIOL DIABET//LOW DENSITY LIPOPROTEIN RETENTION |
8 | 0.0000154682 | HIV INDUCED SYNCYTIUM//MED PATHOBIOLVASC//COMPUTER ASSISTED MOTION ANALYSIS |
9 | 0.0000154062 | TRANSGENES CARDIOVASC CONTROL//SILICONE COLLAR//WHHL RABBIT |
10 | 0.0000151151 | ELECTRONEGATIVE LDL//ELECTRONEGATIVE LOW DENSITY LIPOPROTEIN//ENZYMATICALLY MODIFIED LDL |